 HIGHLANDS RANCH, Colo., March 02, 2022 GLOBE NEWSWIRE -- Vivos Therapeutics, Inc . Vivos or the Company NASDAQ: VVOS, a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities andor mild to moderate obstructive sleep apnea OSA and snoring, today announced that Kirk Huntsman, Chief Executive Officer, will participate in the following upcoming conferences. 